Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane pharmacokinetics during 48-hour ICU sedation in obese patients using AnaConDa
2010-020044-35Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sevoflurane in None, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Plasma sevoflurane concentration profile. Started May 2010; status: active.
02
Drugs
sevoflurane
Beyond the preview
Go deeper on 2010-020044-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020044-35.